• SENSEX 76,909.68
    -325.78 (--0.42%)
  • BANKNIFTY 57,262.40
    -235.40 (--0.41%)
  • Aster DM Quality
    766.10 519.80(%)
  • Dhoot Transmission
    1,436.85 1,306.25(%)
  • Oberoi Realty
    1,831.50 1,390.15(%)
  • Abbott India
    26,302.50 25,164.00(%)
  • Pfizer
    4,965.00 5,878.55(%)
  • Cupid
    291.00 298.95(%)
  • Cyient
    902.75 1,282.40(%)
  • HDFC Bank
    715.05 722.00(%)
  • Netweb Technol.
    5,024.00 2,037.65(%)
  • Himadri Special
    702.00 420.00(%)
  • SBI
    1,041.30 798.60(%)
  • Reliance Industries
    1,304.00 1,250.55(%)
  • Bharti Airtel
    1,921.35 1,745.00(%)
  • Kaynes Tech
    3,825.00 7,705.00(%)
  • Alkem Lab
    5,369.15 5,085.00(%)
  • Molbio Diagnosti
    1,013.65 925.80(%)
  • ICICI Bank
    1,391.10 1,187.55(%)
  • Vedant Fashions
    545.15 794.55(%)
  • Triveni Turbine
    561.35 428.50(%)
  • Power Fin.Corpn.
    376.50 486.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Piramal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Piramal Ajay G
  • BSE Code : 76066.0
  • ISIN : INE0DK501011
210.53 6 (2.83%)
  • As on 19 Aug 2026 (EOD)

  • Today’s Low

    200.10

  • Today’s High

    211.60

  • Open

    200.10

  • Perv Close

    204.73

  • 52W Low

    132.30

  • 52W High

    218.50

Key Indicators

  • P/E(TTM)

    36.18

  • Mar.Cap (₹Cr.)

    28,028.87

  • Div & Yield %

    0.00

  • Book Value(₹)

    61.18

  • Debt-Equity Ratio

    2.83

  • AGM Date

    18-Aug-2026

  • EPS

    5.82

  • P/E Ratio

    36.18

Financials Ratios

  • Debt-Equity Ratio

    0.70

  • Mar.Cap (₹Cr.)

    28,028.87

  • RONW (%)

    0.22

  • ROCE (%)

    5.40

Score Board

  • Equity (₹ in Cr.)

    1,331.35

  • BV (₹)

    61.20

  • Sales( ₹ in Cr.)

    4,782.01

  • NP (in Cr.)

    767.53

  • NP Var(%)

    11.0

  • Div%

    0.0

  • CPS (₹)

    7.70

  • EPS (₹)

    5.80

  • Traded Value (₹ in Lakhs)

    28,031.53

  • 52 Week High

    218.50

  • 52 Week Low

    132.30

  • Price BSE

    211.0

  • Price NSE

    211.00

  • Market Capital( in Cr.)

    28,031.53

  • P/C Ratio

    27.50

  • P/E Ratio

    36.60

  • Price Vs.BV

    5.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 4,782.01 5,285.71 4,390.11 3,443.22 3,340.42 2,938.81
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,782.01 5,285.71 4,390.11 3,443.22 3,340.42 2,938.81
Other Income 662.73 207.35 202.06 341.07 224.79 216.20
Stock Adjustments 138.98 84.57 61.62 -53.31 32.66 -57.86
Total Income 5,583.72 5,577.63 4,653.79 3,730.98 3,597.87 3,097.15
EXPENDITURE :            
Raw Materials 2,208.88 2,330.53 2,170.46 1,715.17 1,594.17 1,169.91
Power and Fuel Cost 131.53 131.62 112.89 107.94 83.83 68.08
Employee Cost 744.82 736.19 613.93 548.50 448.03 395.15
Other Manufacturing Expenses 292.60 284.35 251.57 259.29 299.83 252.74
Selling and Administration Expenses 746.52 746.69 620.04 485.63 427.82 258.75
Miscellaneous Expenses 247.15 100.46 64.92 182.81 59.20 117.39
Employee Benefit Expenses 744.82 736.19 613.93 548.50 448.03 395.15
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,371.50 4,329.84 3,833.81 3,299.34 2,912.88 2,262.02
Operating Profit 1,212.22 1,247.79 819.98 431.64 684.99 835.13
Interest 79.95 114.56 107.10 115.87 57.29 4.71
Gross Profit 1,132.27 1,133.23 712.88 315.77 627.70 830.42
Depreciation 255.50 222.09 205.26 192.08 165.37 143.64
Profit Before Tax 876.77 911.14 507.62 123.69 462.33 686.78
Current Tax 114.68 199.44 112.48 38.77 110.82 104.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 62.08 20.30 3.92 15.42 -16.03 10.30
Reported Net Profit 700.01 691.40 391.22 69.50 367.54 571.50
Extraordinary Items -67.52 2.40 3.34 -3.14 -10.64 15.44
Adjusted Net Profit 767.53 689.00 387.88 72.64 378.18 556.06
Adjustment below Net Profit -13.89 1.05 -3.79 -2.59 31.70 -2.46
P & L Balance brought forward 2,037.21 1,359.23 971.79 918.28 569.04 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 18.54 14.47 0.00 13.40 50.00 0.00
P & L Balance carried down 2,704.79 2,037.21 1,359.22 971.79 918.28 569.04
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 1.40 1.10 0.00 5.60 0.00
Dividend Per Share(Rs) 0.00 0.14 0.11 0.00 0.56 0.00
Earnings Per Share-Unit Curr 5.27 5.22 2.96 0.58 3.10 5.75
Earnings Per Share(Adj)-Unit Curr 5.27 5.22 2.96 0.57 - -
Book Value 61.34 56.27 50.74 44.09 43.20 41.23
Book Value(Adj)-Unit Curr 61.34 56.27 50.74 43.06 - -

Shareholding Pattern

  • Promoter Group

    34.80%

  • Public Share Holding

    64.72%

  • Custodian

    0.48%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 91,750,276 6.89 91,750,276 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,570,932 0.19 2,570,932 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 369,003,464 27.72 369,003,464 5
Others 0 0.00 0 0
Sub Total 463,324,672 34.80 463,324,672 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 5,409 0.00 5,409 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9,868 0.00 9,868 3
Foreign Bank 1,332 0.00 1,332 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 166,633,111 12.52 166,633,111 169
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13,531,568 1.02 13,531,568 10
Mutual Funds / UTI 175,491,298 13.18 175,491,298 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,001,359 0.38 5,001,359 28
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 360,673,945 27.09 360,673,945 239
2] Non Institution
Bodies Corporate 15,216,097 1.14 15,216,097 1,314
Clearing Members 905,098 0.07 905,098 76
Directors of their Relatives 271,868 0.02 271,868 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 17,315,548 1.30 17,315,548 2
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 15,770,416 1.18 15,770,416 7,128
Foreign Non Institution Other 238,663,700 17.93 238,663,700 1
Hindu Undivided Families 6,271,291 0.47 6,271,291 6,187
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 46,859,494 3.52 46,859,494 718
Individuals holding nominal share capital up to Rs. 1 lakh 146,746,431 11.02 146,746,431 445,208
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 30,127 0.00 30,127 12
Others 3,228,564 0.24 3,228,564 1
Sub Total 501,019,831 37.63 501,019,831 460,837
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 6,329,682 0.48 6,329,682 3
Total Shares held by Custodians and against which Depository Receipts have been issued 6,329,682 0.48 6,329,682 3
Grand Total ( A + B + C ) 1,331,348,130 100.00 1,331,348,130 461,096

Company Background

Piramal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Piramal Pharma Ltd
  • BSE Code : 76066.0
  • ISIN : INE0DK501011

  • Incorporation Year

    2020

  • Registered Office

    Ananta Bldg Piramal Corporate
    Park LBS Marg Kurla west, Mumbai,
    Maharashtra-400070

  • Telephone

  • FAX

  • Chairman

    Nandini Piramal

  • Managing Director

  • Company Secretary

    Maneesh Sharma

  • Auditor

    Suresh Surana & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Piramal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Piramal Pharma 210.55 5,444.74 4,782.01 40.03 10.77
Abbott India 26,587.05 7,217.19 6,929.05 34.99 43.78
Astrazeneca Phar 7,649.85 2,304.07 2,275.58 112.75 27.86
Glaxosmi. Pharma 2,883.20 3,932.76 3,790.20 46.06 58.17
Novartis India 1,594.05 398.23 356.27 40.25 16.64
Cipla 1,431.85 20,102.60 18,979.95 37.63 13.88
Bliss GVS Pharma 545.45 773.53 729.81 50.65 12.51
Amrutanjan Healt 488.65 469.50 451.82 26.17 21.89
Fermenta Biotec. 454.50 474.15 450.25 21.22 18.77
Guj. Themis Bio. 372.35 152.47 150.80 83.30 27.21
Ambalal Sarabhai 47.70 19.52 3.94 88.33 6.77